Diou Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diou Luo has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Javier López Soto
Brown University
1 shared publication Elizabeth A. Heller
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania 1910-5158
1 shared publication- Michael J. Gandal
University of Pennsylvania
1 shared publication Sika Zheng
Division of Biomedical Sciences, University of California at Riverside, Riverside, California 92521
1 shared publication- Thomas Gonatopoulos-Pournatzis
RNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, MD 21702, USA
1 shared publication
Latest Publications
- Open Access
- 16 October 2019
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 39 (42) , 8193-8199
Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions
Many cellular and physiological processes are coordinated by regulatory networks that produce a remarkable complexity of transcript isoforms. In the mammalian nervous system, alternative pre-mRNA splicing generates functionally distinct isoforms that play key roles in normal physiology, supporting development, plasticity, complex behaviors, and cognition. Neuronal splicing programs controlled by RNA-binding proteins, are influenced by chromatin modifications and can exhibit neuronal subtype specificity. As highlighted in recent publications, aberrant alternative splicing is a major contributor to disease phenotypes. Therefore, understanding the underlying mechanisms of alternative splicing regulation and identifying functional splicing isoforms with critical phenotypic roles are expected to provide a comprehensive resource for therapeutic development, as illuminated by recent successful interventions of spinal muscular atrophy. Here, we discuss the latest progress in the study of the emerging complexity of alternative splicing mechanisms in neurons, and how these findings inform new therapies to correct and control splicing defects.
- 16 October 2019
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 39 (42) , 8193-8199
Open AccessMechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions
Many cellular and physiological processes are coordinated by regulatory networks that produce a remarkable complexity of transcript isoforms. In the mammalian nervous system, alternative pre-mRNA splicing generates functionally distinct isoforms that play key roles in normal physiology, supporting development, plasticity, complex behaviors, and cognition. Neuronal splicing programs controlled by RNA-binding proteins, are influenced by chromatin modifications and can exhibit neuronal subtype specificity. As highlighted in recent publications, aberrant alternative splicing is a major contributor to disease phenotypes. Therefore, understanding the underlying mechanisms of alternative splicing regulation and identifying functional splicing isoforms with critical phenotypic roles are expected to provide a comprehensive resource for therapeutic development, as illuminated by recent successful interventions of spinal muscular atrophy. Here, we discuss the latest progress in the study of the emerging complexity of alternative splicing mechanisms in neurons, and how these findings inform new therapies to correct and control splicing defects.